$TRNS
TRANSCAT INC

2024 Q4 Form 10-Q Financial Statement

#000143774924033612 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $67.83M
YoY Change 8.0%
Cost Of Revenue $46.62M
YoY Change 9.23%
Gross Profit $21.21M
YoY Change 5.37%
Gross Profit Margin 31.27%
Selling, General & Admin $17.47M
YoY Change -5.47%
% of Gross Profit 82.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.400M
YoY Change 33.74%
% of Gross Profit 20.75%
Operating Expenses $17.47M
YoY Change -5.47%
Operating Profit $3.735M
YoY Change 127.33%
Interest Expense $210.0K
YoY Change -123.6%
% of Operating Profit 5.62%
Other Income/Expense, Net -$232.0K
YoY Change -72.41%
Pretax Income $3.713M
YoY Change 362.97%
Income Tax $427.0K
% Of Pretax Income 11.5%
Net Earnings $3.286M
YoY Change 614.35%
Net Earnings / Revenue 4.84%
Basic Earnings Per Share $0.36
Diluted Earnings Per Share $0.35
COMMON SHARES
Basic Shares Outstanding 9.199M 9.145M
Diluted Shares Outstanding 9.282M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.82M
YoY Change 1884.58%
Cash & Equivalents $23.82M
Short-Term Investments $0.00
Other Short-Term Assets $6.241M
YoY Change 78.31%
Inventory $15.55M
Prepaid Expenses
Receivables $48.93M
Other Receivables $628.0K
Total Short-Term Assets $95.17M
YoY Change 46.02%
LONG-TERM ASSETS
Property, Plant & Equipment $64.80M
YoY Change 81.78%
Goodwill $138.1M
YoY Change 29.86%
Intangibles $24.36M
YoY Change 5.21%
Long-Term Investments
YoY Change
Other Assets $1.096M
YoY Change 1.2%
Total Long-Term Assets $228.4M
YoY Change 24.78%
TOTAL ASSETS
Total Short-Term Assets $95.17M
Total Long-Term Assets $228.4M
Total Assets $323.6M
YoY Change 30.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.04M
YoY Change 4.15%
Accrued Expenses $11.09M
YoY Change -3.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.386M
YoY Change 4.06%
Total Short-Term Liabilities $26.52M
YoY Change -5.66%
LONG-TERM LIABILITIES
Long-Term Debt $612.0K
YoY Change -98.8%
Other Long-Term Liabilities $18.37M
YoY Change 235.33%
Total Long-Term Liabilities $18.98M
YoY Change -66.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.52M
Total Long-Term Liabilities $18.98M
Total Liabilities $54.80M
YoY Change -50.17%
SHAREHOLDERS EQUITY
Retained Earnings $85.89M
YoY Change 20.94%
Common Stock $183.6M
YoY Change 168.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $268.8M
YoY Change
Total Liabilities & Shareholders Equity $323.6M
YoY Change 30.35%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $3.286M
YoY Change 614.35%
Depreciation, Depletion And Amortization $4.400M
YoY Change 33.74%
Cash From Operating Activities $6.835M
YoY Change -18.92%
INVESTING ACTIVITIES
Capital Expenditures $3.959M
YoY Change 48.28%
Acquisitions
YoY Change
Other Investing Activities $95.00K
YoY Change -100.95%
Cash From Investing Activities -$3.864M
YoY Change -69.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.411M
YoY Change -144.51%
NET CHANGE
Cash From Operating Activities 6.835M
Cash From Investing Activities -3.864M
Cash From Financing Activities -1.411M
Net Change In Cash 1.560M
YoY Change -243.12%
FREE CASH FLOW
Cash From Operating Activities $6.835M
Capital Expenditures $3.959M
Free Cash Flow $2.876M
YoY Change -50.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
TRANSCAT INC
dei Entity Central Index Key
EntityCentralIndexKey
0000099302
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
4000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
565000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
544000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9199277
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9199277
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8839299
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8839299
CY2024Q1 us-gaap Investments
Investments
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
100000 usd
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-03905
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0874418
dei Entity Address Address Line1
EntityAddressAddressLine1
35 Vantage Point Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Rochester
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14624
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
352-7777
dei Security12b Title
Security12bTitle
Common Stock, $0.50 par value
dei Trading Symbol
TradingSymbol
TRNS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9199277
CY2024Q3 us-gaap Revenues
Revenues
67826000 usd
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
us-gaap Revenues
Revenues
134533000 usd
us-gaap Revenues
Revenues
123402000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46620000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42679000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90672000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
84567000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
21206000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
20125000 usd
us-gaap Gross Profit
GrossProfit
43861000 usd
us-gaap Gross Profit
GrossProfit
38835000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8181000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6856000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15982000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13325000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9290000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11626000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19045000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19227000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
17471000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18482000 usd
us-gaap Operating Expenses
OperatingExpenses
35027000 usd
us-gaap Operating Expenses
OperatingExpenses
32552000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3735000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1643000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8834000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6283000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
76000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
890000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
128000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1704000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
286000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
-0 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
598000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
-0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-232000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
49000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-363000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-841000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
107000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1719000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3713000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
802000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8941000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4564000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
427000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1247000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1155000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3286000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
us-gaap Net Income Loss
NetIncomeLoss
7694000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9160000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7819000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9107000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7732000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9282000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7948000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9222000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7840000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3286000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
us-gaap Net Income Loss
NetIncomeLoss
7694000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
381000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-352000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
221000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
124000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
386000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-346000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
231000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
136000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3672000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7925000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3545000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23815000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19646000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15533000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48933000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47779000 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
628000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
506000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
15549000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
17418000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6241000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4276000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
95166000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
105158000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47493000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38944000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
138127000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
105585000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24362000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19987000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17309000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16823000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1096000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1055000 usd
CY2024Q3 us-gaap Assets
Assets
323553000 usd
CY2024Q1 us-gaap Assets
Assets
287552000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13043000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11495000 usd
CY2024Q3 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
11092000 usd
CY2024Q1 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
19665000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2386000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2339000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26521000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
33499000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
612000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1817000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9297000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9291000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14661000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14873000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3705000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2903000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
54796000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
62383000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4600000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4420000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
178986000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
141624000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-718000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-949000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
85889000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
80074000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
268757000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
225169000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
323553000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287552000 usd
us-gaap Net Income Loss
NetIncomeLoss
7694000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-43000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
6000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
23000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8513000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6078000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
108000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
347000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1623000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2171000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1746000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2384000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2597000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3376000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1918000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-465000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1525000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3969000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6178000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1677000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15759000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15972000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7633000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5444000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15858000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12882000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15533000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7958000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18326000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
5288000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1158000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1112000 usd
trns Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
838000 usd
trns Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
384000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3026000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2247000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3346000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2313000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-286000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-244000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4169000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-285000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19646000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1531000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23815000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1246000 usd
trns Interest Paid Received Excluding Capitalized Interest Operating Activities
InterestPaidReceivedExcludingCapitalizedInterestOperatingActivities
-462000 usd
trns Interest Paid Received Excluding Capitalized Interest Operating Activities
InterestPaidReceivedExcludingCapitalizedInterestOperatingActivities
1680000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5534000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1099000 usd
us-gaap Stock Issued1
StockIssued1
35479000 usd
us-gaap Stock Issued1
StockIssued1
34769000 usd
trns Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition
NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition
1306000 usd
trns Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition
NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition
4589000 usd
trns Noncash Or Part Noncash Acquisition Contingent Consideration Treated As Equity
NoncashOrPartNoncashAcquisitionContingentConsiderationTreatedAsEquity
750000 usd
trns Noncash Or Part Noncash Acquisition Contingent Consideration Treated As Equity
NoncashOrPartNoncashAcquisitionContingentConsiderationTreatedAsEquity
0 usd
trns Reclassification Of Property And Equipment To Inventory
ReclassificationOfPropertyAndEquipmentToInventory
692000 usd
trns Reclassification Of Property And Equipment To Inventory
ReclassificationOfPropertyAndEquipmentToInventory
494000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99630000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7030000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
930000 usd
CY2023Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
482000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2949000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
110720000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28123000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1946000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1241000 usd
CY2023Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-346000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
138252000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
225169000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33039000 usd
CY2024Q2 trns Adjustments To Additional Paid In Capital Contingent Consideration
AdjustmentsToAdditionalPaidInCapitalContingentConsideration
750000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1620000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
697000 usd
CY2024Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-155000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
4408000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
262288000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3277000 usd
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1406000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
926000 usd
CY2024Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
386000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3286000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
268757000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates: </b>The preparation of Transcat’s Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States ("GAAP") requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but <em style="font: inherit;">not</em> limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements <em style="font: inherit;"> may </em>change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2024Q3 trns Revenue Recognition Percentage Of Net Sales
RevenueRecognitionPercentageOfNetSales
1 pure
CY2023Q3 trns Revenue Recognition Percentage Of Net Sales
RevenueRecognitionPercentageOfNetSales
1 pure
trns Revenue Recognition Percentage Of Net Sales
RevenueRecognitionPercentageOfNetSales
1 pure
trns Revenue Recognition Percentage Of Net Sales
RevenueRecognitionPercentageOfNetSales
1 pure
CY2024Q3 us-gaap Investments
Investments
100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-400000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
100000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2024Q3 trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
CY2023Q3 trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9160000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7819000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9107000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7732000
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
122000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
129000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
115000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
108000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9282000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7948000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9222000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7840000
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37000
CY2024Q1 us-gaap Goodwill
Goodwill
105585000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19987000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
32532000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
8040000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3665000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
10000 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
0 usd
CY2024Q3 us-gaap Goodwill
Goodwill
138127000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24362000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4982000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5508000 usd
CY2024Q3 trns Accrued Incentive Current
AccruedIncentiveCurrent
1277000 usd
CY2024Q1 trns Accrued Incentive Current
AccruedIncentiveCurrent
4182000 usd
CY2024Q3 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
3201000 usd
CY2024Q1 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
2510000 usd
CY2024Q3 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
514000 usd
CY2024Q1 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
2577000 usd
CY2024Q3 trns Accrued Sales Tax Current
AccruedSalesTaxCurrent
652000 usd
CY2024Q1 trns Accrued Sales Tax Current
AccruedSalesTaxCurrent
813000 usd
CY2024Q3 trns Accrued Contingent Consideration
AccruedContingentConsideration
0 usd
CY2024Q1 trns Accrued Contingent Consideration
AccruedContingentConsideration
529000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2926000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
466000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
620000 usd
CY2024Q3 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
11092000 usd
CY2024Q1 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
19665000 usd
CY2024Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1132000 usd
CY2024Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1134000 usd
CY2024Q3 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
1647000 usd
CY2024Q1 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
1647000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
806000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
120000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
122000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3705000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2903000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1100000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
600000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
234000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
112.93
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
63.04
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10522000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
72000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
58.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2838000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
CY2024Q3 us-gaap Revenues
Revenues
67826000 usd
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
us-gaap Revenues
Revenues
134533000 usd
us-gaap Revenues
Revenues
123402000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
21206000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
20125000 usd
us-gaap Gross Profit
GrossProfit
43861000 usd
us-gaap Gross Profit
GrossProfit
38835000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
17471000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18482000 usd
us-gaap Operating Expenses
OperatingExpenses
35027000 usd
us-gaap Operating Expenses
OperatingExpenses
32552000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3735000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1643000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8834000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6283000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-841000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
107000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1719000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
427000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1247000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1155000 usd
CY2024Q3 us-gaap Other General Expense
OtherGeneralExpense
449000 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
1183000 usd
us-gaap Other General Expense
OtherGeneralExpense
1140000 usd
us-gaap Other General Expense
OtherGeneralExpense
2874000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3286000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
us-gaap Net Income Loss
NetIncomeLoss
7694000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
CY2024Q3 us-gaap Revenues
Revenues
67826000 usd
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
us-gaap Revenues
Revenues
134533000 usd
us-gaap Revenues
Revenues
123402000 usd
CY2024Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
67826000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
68948000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
134533000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
137828000 usd
CY2024Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3286000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
435000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7545000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
2879000 usd
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.36
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.06
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.83
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.37
CY2024Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.35
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.05
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.82
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.37
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
500000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
800000 usd
CY2024Q3 trns Unpaid Amounts For Other Holdbacks
UnpaidAmountsForOtherHoldbacks
1600000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
trns Payments For Other Holdbacks
PaymentsForOtherHoldbacks
300000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
400000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
200000 usd

Files In Submission

Name View Source Status
0001437749-24-033612-index-headers.html Edgar Link pending
0001437749-24-033612-index.html Edgar Link pending
0001437749-24-033612.txt Edgar Link pending
0001437749-24-033612-xbrl.zip Edgar Link pending
ex_721634.htm Edgar Link pending
ex_721635.htm Edgar Link pending
ex_721636.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trns-20240928.xsd Edgar Link pending
trns20240928_10q.htm Edgar Link pending
trns-20240928_def.xml Edgar Link unprocessable
trns-20240928_lab.xml Edgar Link unprocessable
trns-20240928_pre.xml Edgar Link unprocessable
trns20240928_10q_htm.xml Edgar Link completed
trns-20240928_cal.xml Edgar Link unprocessable